Home
INTZ
INTZ News

Latest Intrusion Inc. (INTZ) News on July 27, 2024

Why the Market Dipped But Intrusion Inc. (INTZ) Gained Today

Zacks

3 days ago

Why the Market Dipped But Intrusion Inc. (INTZ) Gained Today

Intrusion Inc. (INTZ) Rises As Market Takes a Dip: Key Facts

Zacks

9 days ago

Intrusion Inc. (INTZ) Rises As Market Takes a Dip: Key Facts

Why Intrusion Inc. (INTZ) Dipped More Than Broader Market Today

Zacks

a month ago

Why Intrusion Inc. (INTZ) Dipped More Than Broader Market Today

GuruFocus.com

2 months ago

Intrusion Inc (INTZ) Q1 2024 Earnings Call Transcript Highlights: Strategic Wins Amid Revenue ...

Intrusion Inc. Reports First Quarter 2024 Results

ACCESSWIRE

2 months ago

Intrusion Inc. Reports First Quarter 2024 Results

13 Penny Stocks with Insider Buying in 2024

Insider Monkey

2 months ago

13 Penny Stocks with Insider Buying in 2024

Insider Buying Alert: CEOs Are Buying These 10 Stocks

Insider Monkey

3 months ago

Insider Buying Alert: CEOs Are Buying These 10 Stocks

Intrusion Inc. (INTZ) Stock Moves -1.28%: What You Should Know

Zacks

3 months ago

Intrusion Inc. (INTZ) Stock Moves -1.28%: What You Should Know

Intrusion Inc. to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

ACCESSWIRE

3 months ago

Intrusion Inc. to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Intrusion Inc. (INTZ) Suffers a Larger Drop Than the General Market: Key Insights

Zacks

3 months ago

Intrusion Inc. (INTZ) Suffers a Larger Drop Than the General Market: Key Insights

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 04/26/2024

CEO Anthony Scott Acquires 585,748 Shares of Intrusion Inc (INTZ)

GuruFocus.com

3 months ago

CEO Anthony Scott Acquires 585,748 Shares of Intrusion Inc (INTZ)

Intrusion (INTZ) Announces Purchase of Stake in Klever AI

Zacks

3 months ago

Intrusion (INTZ) Announces Purchase of Stake in Klever AI

Intrusion Inc. Announces Private Placement Subscription Agreement

ACCESSWIRE

3 months ago

Intrusion Inc. Announces Private Placement Subscription Agreement

Intrusion Inc. Announces Acquisition of Minority Stake in Klever AI

ACCESSWIRE

3 months ago

Intrusion Inc. Announces Acquisition of Minority Stake in Klever AI

Intrusion Partner iOne Wins P1.4 Billion Bid for the Commission on Elections Project, Securing National and Local Polls in the Philippines

ACCESSWIRE

3 months ago

Intrusion Partner iOne Wins P1.4 Billion Bid for the Commission on Elections Project, Securing National and Local Polls in the Philippines

Intrusion (INTZ) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

3 months ago

Intrusion (INTZ) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks Industry Outlook Highlights Infinera, NETGEAR and Intrusion

Zacks

4 months ago

Zacks Industry Outlook Highlights Infinera, NETGEAR and Intrusion

3 Networking Stocks to Keep An Eye on in a Troubled Industry

Zacks

4 months ago

3 Networking Stocks to Keep An Eye on in a Troubled Industry

Intrusion Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

4 months ago

Intrusion Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Intrusion Inc. (NASDAQ:INTZ) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Intrusion Inc. (NASDAQ:INTZ) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Intrusion Inc Earnings Call

Intrusion Inc. Reports Fourth Quarter and Full Year 2023 Results

ACCESSWIRE

4 months ago

Intrusion Inc. Reports Fourth Quarter and Full Year 2023 Results

Intrusion, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on Tuesday, March 26, 2024

ACCESSWIRE

4 months ago

Intrusion, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on Tuesday, March 26, 2024

Intrusion Inc. Announces 1-for-20 Reverse Stock Split & Exchange Agreement of Debt to Preferred Stock

ACCESSWIRE

4 months ago

Intrusion Inc. Announces 1-for-20 Reverse Stock Split & Exchange Agreement of Debt to Preferred Stock

Intrusion Announces Customer Wins in the Philippines

ACCESSWIRE

6 months ago

Intrusion Announces Customer Wins in the Philippines

LifeVantage Corporation (NASDAQ:LFVN) Q2 2024 Earnings Call Transcript

Insider Monkey

6 months ago

LifeVantage Corporation (NASDAQ:LFVN) Q2 2024 Earnings Call Transcript

Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?

Zacks

6 months ago

Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?

Best Momentum Stocks to Buy for January 31st

Zacks

6 months ago

Best Momentum Stocks to Buy for January 31st

Intrusion's CEO Issues Letter to Shareholders

ACCESSWIRE

6 months ago

Intrusion's CEO Issues Letter to Shareholders

New Strong Buy Stocks for January 31st

Zacks

6 months ago

New Strong Buy Stocks for January 31st

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

GlobeNewswire

6 months ago

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

Intrusion Announces Participation in The Microcap Conference

ACCESSWIRE

6 months ago

Intrusion Announces Participation in The Microcap Conference

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

GlobeNewswire

6 months ago

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week

Simply Wall St.

6 months ago

Investors in Sensus Healthcare (NASDAQ:SRTS) from a year ago are still down 60%, even after 24% gain this past week

MariaDB Finalizes Spinoff of Its Geospatial Business

Business Wire

6 months ago

MariaDB Finalizes Spinoff of Its Geospatial Business

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Business Wire

6 months ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Marpai CEO & Director Acquires 84% More Stock

Simply Wall St.

6 months ago

Marpai CEO & Director Acquires 84% More Stock

Mullen Announces Bollinger Motors Receives Vehicle Orders for 40 B4, Class 4 EV Trucks; Valued at Approximately $6 Million

GlobeNewswire

6 months ago

Mullen Announces Bollinger Motors Receives Vehicle Orders for 40 B4, Class 4 EV Trucks; Valued at Approximately $6 Million

Shanchun Huang Responds to SEC Allegations

PR Newswire

6 months ago

Shanchun Huang Responds to SEC Allegations

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers

GlobeNewswire

6 months ago

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Marti Announces up to $2.5M Share Repurchase Program

Business Wire

7 months ago

Marti Announces up to $2.5M Share Repurchase Program

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

GlobeNewswire

7 months ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

Simply Wall St.

7 months ago

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

NeuroSense Recaps Positive 2023 Achievements Including Statistically Significant Slowing of Disease Progression in Phase 2b ALS Trial of PrimeC and Highlights Anticipated 2024 Catalysts

PR Newswire

7 months ago

NeuroSense Recaps Positive 2023 Achievements Including Statistically Significant Slowing of Disease Progression in Phase 2b ALS Trial of PrimeC and Highlights Anticipated 2024 Catalysts

KULR Reduces Workforce by 15% Amid Streamlining Efforts

GlobeNewswire

7 months ago

KULR Reduces Workforce by 15% Amid Streamlining Efforts

Reuters

7 months ago

Cellectar's blood cancer therapy succeeds in trial

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia

GlobeNewswire

7 months ago

Cellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia

ReTo Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

PR Newswire

7 months ago

ReTo Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Zacks

7 months ago

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

CervoMed to Participate in the Emerging Growth Conference 66

GlobeNewswire

7 months ago

CervoMed to Participate in the Emerging Growth Conference 66

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

ACCESSWIRE

7 months ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

7 months ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

EDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…

Zacks Small Cap Research

7 months ago

EDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…

KULR to Introduce KULR ONE MAX at CES 2024

GlobeNewswire

7 months ago

KULR to Introduce KULR ONE MAX at CES 2024

Royalty Management Holding Corporation's Portfolio Company, Ferrox Holdings Ltd, Commences Production from its Tivani Project

ACCESSWIRE

7 months ago

Royalty Management Holding Corporation's Portfolio Company, Ferrox Holdings Ltd, Commences Production from its Tivani Project

Companies Like Paltalk (NASDAQ:PALT) Are In A Position To Invest In Growth

Simply Wall St.

7 months ago

Companies Like Paltalk (NASDAQ:PALT) Are In A Position To Invest In Growth

The Container Store Group, Inc. Announces Two Leadership Promotions

Business Wire

7 months ago

The Container Store Group, Inc. Announces Two Leadership Promotions

MultiMetaVerse Holdings Limited Announces 2023 Unaudited Half Year Financial Results

PR Newswire

7 months ago

MultiMetaVerse Holdings Limited Announces 2023 Unaudited Half Year Financial Results

GeneDx Holdings Corp. (NASDAQ:WGS) Surges 52% Yet Its Low P/S Is No Reason For Excitement

Simply Wall St.

7 months ago

GeneDx Holdings Corp. (NASDAQ:WGS) Surges 52% Yet Its Low P/S Is No Reason For Excitement

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Simply Wall St.

7 months ago

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

36Kr Holdings Inc. (NASDAQ:KRKR) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

36Kr Holdings Inc. (NASDAQ:KRKR) Q3 2023 Earnings Call Transcript

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

GlobeNewswire

8 months ago

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

11 Stocks Under $25 To Buy Now

Insider Monkey

8 months ago

11 Stocks Under $25 To Buy Now

Glatfelter (NYSE:GLT) investors are sitting on a loss of 90% if they invested three years ago

Simply Wall St.

8 months ago

Glatfelter (NYSE:GLT) investors are sitting on a loss of 90% if they invested three years ago

PodcastOne (Nasdaq: PODC) to Present at NobleCon19 - Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference

GlobeNewswire

8 months ago

PodcastOne (Nasdaq: PODC) to Present at NobleCon19 - Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

GlobeNewswire

8 months ago

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

GlobeNewswire

8 months ago

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Huize Holding Ltd Earnings Call

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

Simply Wall St.

8 months ago

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

GlobeNewswire

8 months ago

Huize Reports Third Quarter 2023 Unaudited Financial Results

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire

8 months ago

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

Intrusion Inc. (NASDAQ:INTZ) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Intrusion Inc. (NASDAQ:INTZ) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Intrusion Inc Earnings Call

GlobeNewswire

8 months ago

Huize Partners with Dajia Annuity Insurance to Launch “Dajia Hui Xuan” – A Customized Retirement Annuity Insurance Product

Intrusion, Inc. Reports Third Quarter 2023 Results

ACCESSWIRE

8 months ago

Intrusion, Inc. Reports Third Quarter 2023 Results

Airgain Secures Tier 1 MNO Indoor FWA Antenna Design Win

Business Wire

8 months ago

Airgain Secures Tier 1 MNO Indoor FWA Antenna Design Win

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

GlobeNewswire

8 months ago

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

SAI.TECH Global Corporation Reports Unaudited Financial Results for the Six Months Ended June 30, 2023

GlobeNewswire

8 months ago

SAI.TECH Global Corporation Reports Unaudited Financial Results for the Six Months Ended June 30, 2023

James Gero Bought 73% More Shares In Intrusion

Simply Wall St.

9 months ago

James Gero Bought 73% More Shares In Intrusion

Aptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Aptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call Transcript

Intrusion Announces Securities Purchase Agreement Through a Private Offering

ACCESSWIRE

9 months ago

Intrusion Announces Securities Purchase Agreement Through a Private Offering

Associated Press Finance

9 months ago

Aptose Biosciences: Q3 Earnings Snapshot

ADAMS RESOURCES & ENERGY, INC. TO PRESENT AND HOST 1x1 INVESTOR MEETINGS AT THE 15th ANNUAL SOUTHWEST IDEAS INVESTOR CONFERENCE ON NOVEMBER 15th & 16th IN DALLAS, TX

PR Newswire

9 months ago

ADAMS RESOURCES & ENERGY, INC. TO PRESENT AND HOST 1x1 INVESTOR MEETINGS AT THE 15th ANNUAL SOUTHWEST IDEAS INVESTOR CONFERENCE ON NOVEMBER 15th & 16th IN DALLAS, TX

Aptose Reports Results for the Third Quarter 2023

GlobeNewswire

9 months ago

Aptose Reports Results for the Third Quarter 2023

GuruFocus.com

9 months ago

Candel Therapeutics Inc (CADL) Reports Q3 2023 Financial Results and Clinical Progress

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

9 months ago

Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Paltalk, Inc. (NASDAQ:PALT) Q3 2023 Earnings Call Transcript

Paltalk, Inc. Reports an Increase in Revenue of 5.5% in Third Quarter 2023

GlobeNewswire

9 months ago

Paltalk, Inc. Reports an Increase in Revenue of 5.5% in Third Quarter 2023

GlobeNewswire

9 months ago

Huize Holding Limited to Report Third Quarter 2023 Financial Results on November 17, 2023

Glatfelter Corporation (NYSE:GLT) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Glatfelter Corporation (NYSE:GLT) Q3 2023 Earnings Call Transcript

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

PR Newswire

9 months ago

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Root Inc (ROOT) Q3 2023 Earnings: New Writings Double, Loss Ratio Improves

GuruFocus.com

9 months ago

Root Inc (ROOT) Q3 2023 Earnings: New Writings Double, Loss Ratio Improves

GlobeNewswire

9 months ago

Huize Holding Limited to Hold Annual General Meeting on November 30, 2023

Share on Social Networks: